Intensive Concomitant Chemoradiotherapy in Locally Advanced Unresectable Squamous Cell Carcinoma of the Head and Neck: A Phase II Study of Radiotherapy with Cisplatin and 7-Week Continuous Infusional Fluorouracil

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1192-1200

  Wibault, Pierre ^a   Bensmaïne, Mohamed El Amine ^a   De Forni, Marcel ^a   Armand, Jean Pierre ^a   Bernal, Eduardo Tellez ^a   Guillot, Thierry ^a   Recondo, Gonzalo ^a   Domenge, Christian ^a   Janot, François ^a   Borel, Christian ^a   Luboinski, Bernard ^a   Eschwege, François ^a   Cvitkovic, Esteban ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOTOXICITY; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE RESPONSE; FEMALE; GASTROINTESTINAL TOXICITY; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT COMPLIANCE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029916954     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1192     Document Type: Article

References (50)

1. Dimery N, Hong WK: Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85:95-111, 1993
2. Jaulery C, Rodriguez J, Bunin F, et al: Induction chemotherapy in advanced head and neck tumors. Results of two randomized trials. Int J Radiat Oncol Biol Phys 23:483-489, 1992
3. Paccagnella A, Orlando A, Matchiori C, et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86:265-272, 1994
4. Vokes EE, Schilsky RL, Weichselbaum RR, et al: Induction chemotherapy with cisplatin, fluorouracil and high dose leucovorin for locally advanced head and neck cancer: A clinical and pharmacologic analysis. J Clin Oncol 8:241-247, 1990
5. Clark J, Dreyfuss A, Busse P, et al: Neoadjuvant continous infusion cisplatin, 5-FU and high-dose leucovorin (PFL) for SCCHN: High rates of complete response and definitive radiotherapy as primary site management. Proceedings of the Fourth International Congress on Anti-Cancer Chemotherapy, Paris, France, February 2-5, 1993, p 66 (abstr 34)
6. Vokes EE, Ratain MJ, Mick R, et al: Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: A clinical and pharmacologic analysis. J Clin Oncol 11:360-368, 1993
7. Recondo G, Cvitkovic E, Azli N, et al: Neoadjuvant chemotherapy consisting of cisplatin and continuous infusion of bleomycin and 5-fluorouracil for advanced head and neck cancer. Cancer 68:2109-2119, 1991
8. Bensmaine MA, Guillot T, Tellez Bernal E, et al: Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinoma. Am J Clin Oncol (in press)
9. Vokes EE, Weihselbaum RR: Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911-934, 1990
10. Kish JA, Weaver A, Jacobs J, et al: Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53:1819-1824, 1984
11. Dewit L: Combined treatment of radiation and cisdiaminedichloroplatinum (II): A review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13:403-426, 1987
12. Byfield JC, Calabro-Jones P, Klisak I, et al: Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x-rays. Int J Radiat Oncol Biol Phys 8:1923-1933, 1982
13. Lokich J, Bothe A, Fine N, et al: Phase I study of protracted venous infusion of 5-fluorouracil. Cancer 48:2565-2568, 1981
14. Fabian CJ, Reddy E, Jeweil W, et al: Phase I-II pilot of whole abdominal radiation and concomitant 5-FU as an adjuvant in colon cancer: A Southwest Oncology Group study. Int J Radiat Oncol Biol Phys 15:885-892, 1988
15. Gastrointestinal Tumor Study Group: Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 80:751-755, 1988
16. Byfield JC, Sharp TR, Frankel SS, et al: Phase I and II trial of five-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck. J Clin Oncol 2:406-413, 1984
17. Lusinchi A, Partigan E, Luboinski B, et al: Accelerated radiation therapy in the treatment of very advanced and inoperable head and neck cancers. Int J Radiat Oncol Biol Phys 29:149-152, 1994
18. Bourhis J, Fortin A, Dupuis O, et al: Very accelerated radiation therapy: Preliminary results in locally unresectable head and neck carcinomas. Int J Radiat Oncol Biol Phys 32:747-752, 1995
19. Marcial VA, Pajak TF: Radiation therapy alone or in combination with surgery in head and neck cancer. Cancer 55:2259-2265, 1985
20. Jacobs C: Adjuvant and neoadjuvant treatment of head and neck cancer. Semin Oncol 18:504-514, 1991
21. Lo TC, Wiley AL, Anfield FJ, et al: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Am J Roentgenol 126:229-235, 1976
22. Ratain MJ, Vogelzang NJ: Experimental rationale for continuous infusion chemotherapy, in Lokich JJ (ed): Cancer Chemotherapy by Infusion. Chicago, IL, C Precept, 1987, pp 12-34
23. Weppelmann B, Wheeler RH, Peters GE, et al: A phase I study of prolonged infusion 5-fluorouracil and concomitant radiation therapy in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 20:357-360, 1991
24. Salter MM, Wheeler RH, Peters GE, et al: A phase I study of high dose cisplatin, prolonged infusion 5-fluorouracil, and concomitant conventional function radiation therapy in patients with inoperable squamous cell carcinoma of the head and neck. Am J Clin Oncol 19:461-463, 1992
25. Marcial VA, Pajak TF, Mohieddin M, et al: Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer 66:1861-1868, 1990
26. Wheeler K, Salter MM, Stephens S, et al: Simultaneous therapy with high-dose cisplatin and radiation for unresectable squamous cell cancer of the head and neck: A phase I/II study. Natl Cancer Inst Monogr 6:339-341, 1988
27. Taylor SG, Murthy AK, Coldarelli DD, et al: Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol 7:846-856, 1989
28. Olver I, Hughes P, Smith J, et al: Late effects and survival after simultaneous continuous 5-fluorouracil (5-FU) and radiation in head and neck cancer. Proc Am Soc Clin Oncol 12:890, 1993 (abstr)
29. Recondo G, Benahmed M, Cvitkovic E, et al: 96-hours continuous infusion of cisplatin, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma unexpected anemia. Eur J Cancer Clin Oncol 25:1529-1533, 1989
30. De Forni M, Malet-Martino MC, Jaillais P, et al: Cardiotoxicity of high-dose continuous infusion fluorouracil: A prospective clinical study. J Clin Oncol 10:1795-1801, 1993
31. Taylor SG, Murthy AK, Vannetzel JM, et al: Randomized comparison of neoadjuvant cisplatin and 5-fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12:385-395, 1994
32. Adelstein DJ, Sharan VM, Earle AS, et al: Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65:1685-1691, 1990
33. Cognetti F, Pinnaro P, Ruggeri E, et al: Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. J Clin Oncol 7:829-837, 1989
34. Wendt TG, Hartenstein RC, Wustrow TPU, et al: Cisplatin, fluorouracil with leucovorin calcium enhancement and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: A phase II study. J Clin Oncol 7:471-476, 1989
35. Denham JW, Abott R: Concurrent cisplatin, infusional fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer. J Clin Oncol 9:458-463, 1991
36. Ensley J, Ahmad K, Kish J, et al: Improved response to radiation and concurrent cisplatinum (CACP) in patients with advanced head and neck cancer (SCCHN) that fail induction chemotherapy. Proc Am Soc Clin Oncol 8:652, 1989 (abstr)
37. Wolf GT, Fisher SG: Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 102:934-939, 1992
38. Pfister DG, Harrison LB, Strong EW, et al: Organ-function preservation in advanced oropharynx cancer: Results with induction chemotherapy and radiation. J Clin Oncol 13:671-680, 1995
39. Reyt E, Lavieille JP, Perouse P, et al: Phase II study of weekly induction chemotherapy with cisplatin, 5-fluorouracil and leucovorin in advanced squamous cell carcinomas of the head and neck. Fourth Research Workshop in the Biology, Prevention and Treatment of Head and Neck Cancer, Arlington, VA, September 8-11, 1994 (abstr FP 23)
40. Schellens JHM, Ma J, Planting AST, et al: Exposure to cisplatin and WBC DNA-adduct formation determine the likelhood of response in solid tumor patients, which enables adaptive inter-patient dose-escalation. Seventh International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, Amsterdam, the Netherlands, March 1-4, 1995 (abstr 5.055)
41. Horiot JC, LeFur R, N'Guyen T, et al: Hyperfractionation versus conventional fractionation in oropharynx carcinoma: Final analysis of a randomized trial of the European Organization for Research and Treatment of Cancer Cooperative Group of Radiotherapy. Radiother Oncol 25:231-241, 1992
42. Department of Veteran Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
43. Lefebvre JL, Sahmond T: Larynx preservation in hypopharynx squamous cell carcinoma: Preliminary results of a randomized study (EORTC 24891). Proc Am Soc Clin Oncol 13:283, 1994 (abstr)
44. Cvitkovic E: Neoadjuvant chemotherapy (NACT) with epirubicin (Epi), cisplatin (CDDP), bleomycin (Bleo) (BEC) in undifferenciated nasopharyngeal cancer (UCNT): Preliminary results of an international phase III trial. Proc Am Soc Clin Oncol 13:283, 1994 (abstr)
45. Merlano V, Rosso R, Benasso M, et al: Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327:1115-1121, 1992
46. Vokes EE, Weichselbaum RR, Mick R, et al: Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 84:877-882, 1992
47. Leyvraz S, Pasche P, Bauer J, et al: Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: Four year results of a phase I-II study. J Clin Oncol 12:1876-1885, 1994
48. Vokes EE, Kies M, Haraf DJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 13:876-883, 1995
49. Zattertrom UK, Wennerberg J, Ewers SB, et al: Prognostic factors in head and neck cancer: Histologic grading, DNA ploidy. and nodal status. Head Neck 13:477-487, 1991
50. Janot F, Cvitkovic E, Piekarski D, et al: Correlation between nodal density in contrasted scans and response to cisplatin-based chemotherapy in head and neck squamous cell cancer: A prospective validation. Head Neck 15:222-229, 1993